How do startups decide between trade secret and patent protection? What does the analysis look like? Sandy Chan, Executive Director & General Counsel at IP Counsel Cafe, speaks with Kevin Brown, Vice President of IP at Recursion Pharmaceuticals, a clinical-stage biotechnology company that combines experimental biology and automation with artificial intelligence to discover potential drugs; and Stephanie Southwick, Legal Counsel and Investment Manager at Omni Bridgeway, a global leader in dispute resolution finance.

March 15, 2021
Length: 41:26